Business
Premier Biomedical and HealthWarehouse Team Up to Fight Opioid Pain Medication Abuse
Premier Biomedical and HealthWarehouse Team Up to Fight Opioid Pain Medication Abuse.
About this update from Premier Biomedical Inc
[{"type":"text","content":"\n\n JACKSON CENTER, Pa., Jan. 11, 2018 (GLOBE NEWSWIRE) -- Premier Biomedical, Inc. (OTC:BIEI) announced the signing of an agreement with HealthWarehouse.com, Inc. (OTC:HEWA) to market, sell and distribute Premier’s topical pain relief products.  HealthWarehouse.com is the nation’s largest on-line distributor of prescription and over-the-counter drugs and health supplements.  This augments Premier’s existing internet sales through their website, www.painreliefmeds.com, and other direct outlets announced in earlier press releases. The agreement covers not only Premier’s existing five pain relief products, but also those planned for the future.  The deal also includes the right of HealthWarehouse.com to advertise these products in their catalogs.\n Premier Biomedical’s existing topical pain relief products include a 96-hour topical skin patch, oil-based and water-based roll-ons, an oil-based spray and the newly introduced oil-based ointment.  All of Premier’s products are made from all-natural, non-GMO, solvent- and pesticide-free ingredients. Joe Peters, CEO of HealthWarehouse.com, Inc., stated, “People suffering with pain desperately need an alternative to opioid treatment. HealthWarehouse acts as an advocate to help consumers make their health conditions more manageable by increasing the accessibility of prescription and OTC products through lower prices and online access. Premier Biomedical’s complete line of pain relief products provides an affordable, high quality, pain relief alternative to our customer base.” William A. Hartman, President & CEO of Premier Biomedical, Inc., stated, “We are very excited that we have been able to secure HealthWarehouse as a partner to provide these opioid alternative pain relief products to a much wider customer base. Once people try our products, they will agree that they outperform every other competitive product in relieving pain and suffering, without the dangerous and addictive side-effects associated with opioids.” Hartman continued, “This represents a significant increase in our business potential, and we look forward to an expansion of sales now, and in the future.” For more information please contact:William A. HartmanPresident and CEOPremier Biomedical, Inc.Pain Relief Meds(724) 63...